Unilateral intraocular mastocytosis and anterior uveitis in a dog with subcutaneous mast cell tumors
- 11 April 2013
- journal article
- case report
- Published by Wiley in Veterinary Ophthalmology
- Vol. 17 (2) , 131-138
Abstract
A 9‐year‐old male castratedScottish terrier was referred to the Radiation Oncology Service at theWilliamR.PritchardVeterinaryMedicalTeachingHospital for palliative radiation therapy of an incompletely excised, recurrent subcutaneous mast cell tumor (MCT) located over the right scapula, and surgical removal of a perianal MCT. Three weeks after initial presentation and prior to the fifth radiation treatment, the patient was presented with cloudiness of the left eye of 3–7 days duration. Ophthalmic consultation revealed 3+ aqueous flare with a dependent, swirling component filling approximately one‐third of the anterior chamber. Aqueocentesis was performed under general anesthesia. Cytology revealed mast cells with highly atypical morphology and considered most consistent with neoplasia. The patient died 7 months after pathologic diagnosis of MCT on the right shoulder and 2 months after the cytologic diagnosis of malignant mast cells in the left anterior chamber. To the authors' knowledge, this is the first report of intraocular involvement in a mammal with MCTs, described here as intraocular mastocytosis.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of Drug Permeabilities Across the Blood–Retinal Barrier, Blood–Aqueous Humor Barrier, and Blood–Brain BarrierJournal of Pharmaceutical Sciences, 2011
- Canine conjunctival mast cell tumors: a retrospective studyVeterinary Ophthalmology, 2011
- Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological BehaviorVeterinary Pathology, 2010
- Distribution, metabolism, and excretion of toceranib phosphate (Palladia™, SU11654), a novel tyrosine kinase inhibitor, in dogsJournal of Veterinary Pharmacology and Therapeutics, 2010
- Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical ExcisionClinical Cancer Research, 2009
- Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in PrognosticationVeterinary Pathology, 2007
- Anterior chamber infiltration in a patient with Ph+ acute lymphoblastic leukemia in remission with imatinibAmerican Journal of Ophthalmology, 2005
- Treatment of Canine Mast Cell Tumors with CCNU (Lomustine)Journal of Veterinary Internal Medicine, 1999
- The prognosis following surgical removal of mastocytomas in dogsJournal of Small Animal Practice, 1973
- Ocular complications after therapeutic irradiation.British Journal of Ophthalmology, 1970